Estrogen Receptor β2 and β5 are Associated with Poor Prognosis in Prostate Cancer, and Promote Cancer Cell Migration and Invasion

DSpace/Manakin Repository

Estrogen Receptor β2 and β5 are Associated with Poor Prognosis in Prostate Cancer, and Promote Cancer Cell Migration and Invasion

Citable link to this page

 

 
Title: Estrogen Receptor β2 and β5 are Associated with Poor Prognosis in Prostate Cancer, and Promote Cancer Cell Migration and Invasion
Author: Leung, Yuet-Kin; Lam, Hung-Ming; Song, Dan; Levin, Linda; Ho, Shuk-Mei; Wu, Shulin; Cheng, Liang; Wu, Chin-Lee

Note: Order does not necessarily reflect citation order of authors.

Citation: Leung, Yuet-Kin, Hung-Ming Lam, Shulin Wu, Dan Song, Linda Levin, Liang Cheng, Chin-Lee Wu, and Shuk-Mei Ho. 2010. Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocrine-Related Cancer 17(3): 675-689.
Full Text & Related Files:
Abstract: Estrogens play a pivotal role in the development and progression of prostate cancer (PCa). Their actions are mediated by estrogen receptors (ERs), particularly ERβ in the prostate epithelium. With the discovery of ERβ isoforms, data from previous studies that focused principally on the wild-type ERβ (ERβ1) may not be adequate in explaining the still controversial role of ERβ(s) in prostate carcinogenesis. In this study, using newly generated isoform-specific antibodies, immunohistochemistry (IHC) was performed on a tumor microarray comprised of 144 specimens. IHC results were correlated with pathological and clinical follow-up data to delineate the distinct roles of ERβ1, ERβ2, and ERβ5 in PCa. ERβ2 was commonly found in the cytoplasm and was the most abundant isoform followed by ERβ1 localized predominantly in the nucleus, and ERβ5 was primarily located in the cytoplasm. Logistic regression analyses demonstrated that nuclear ERβ2 (nERβ2) is an independent prognostic marker for prostate specific antigen (PSA) failure and postoperative metastasis (POM). In a Kaplan–Meier analysis, the combined expression of both nERβ2 and cytoplasmic ERβ5 identified a group of patients with the shortest POM-free survival. Cox proportional hazard models revealed that nERβ2 predicted shorter time to POM. In concordance with IHC data, stable, ectopic expression of ERβ2 or ERβ5 enhanced PCa cell invasiveness but only PCa cells expressing ERβ5 exhibited augmented cell migration. This is the first study to uncover a metastasis-promoting role of ERβ2 and ERβ5 in PCa, and show that the two isoforms, singularly and conjointly, have prognostic values for PCa progression. These findings may aid future clinical management of PCa.
Published Version: doi://10.1677/ERC-09-0294
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891483/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:5141357
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters